M.S. TURCHINА, M.V. BUKREEVA, ZH.E. ANNENKOVA, YU.M. MOROZOV, T.I. OBOLENSKAYA

 Orel State University named after I.S. Turgenev, Orel

 Contact details:

Turchina M.S. — PhD (medicine), Associate professor of the Department of Internal Diseases

Address: 95 Komsomolskaya St., Orel, Russian Federation, 302026, tel.: +7-961-625-92-98, e-mail: turchina-57@mail.ru

 Patients with COVID-19 often suffer from a variety of gastrointestinal disorders. Often this is directly related to the effect of the virus on the epithelial cells of the gastrointestinal tract, as well as the prescription of drugs for the new coronavirus infection treatment. In some patients, gastrointestinal disturbances precede the onset of respiratory symptoms and remain for a long time after recovery, significantly reducing the quality of life. Approximately every second patient who had a COVID-19 infection suffers from stool disorders and dyspeptic symptoms. The most common variant of post-covid lesions of the gastrointestinal tract is functional dyspepsia and irritable bowel syndrome, which outpatient doctors have recently encountered more and more often. In most cases, the attending physician pays more attention to the pulmonary and cardiological manifestations of coronavirus infection, while the symptoms of gastrointestinal lesions are considered minor.

The purpose of this article — is to consider possible methods for correcting the functional pathology of the gastrointestinal tract in patients after a COVID-19 infection.

Key words: functional disorders of the gastrointestinal tract, new coronavirus infection, outpatient treatment.

REFERENCES

1. Wong S.H., Lui R.N., Sung J.J. Covid-19 and the digestive system. J Gastroenterol Hepatol, 2020, vol. 35 (5), pp. 744–748. DOI: 10.1111/jgh.1504
2. Bakharev S.D., Baulo E.V., Bykova S.V., Dbar S.R., Parfenov A.I. COVID-19 and the small intestine. Terapevticheskiy arkhiv, 2021, no. 93 (3), pp. 343–347 (in Russ.). DOI: 10.26442/00403660.2021.03.200662
3. Maev I.V., Shpektor A.V., Vasil’eva E.Yu. et al. New coronavirus infection COVID-19: extrapulmonary manifestations. Terapevticheskiy arkhiv, 2020, no. 92 (8), pp. 4–11 (in Russ.). DOI: 10.26442/00403660.2020.08.000767
4. Turchina M.S., Mishina A.S., Veremeychik A.L., Reznikov R.G. Clinical features of lesions of the gastrointestinal tract in patients with a new coronavirus infection COVID-19. Aktual’nye problemy meditsiny, 2021, no. 44 (1), pp. 5–15 (in Russ.). DOI: 10.18413/2687-0940-2021-44-1-5-15
5. Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B beta coronaviruses. Nat. Microbiol, 2020, vol. 5 (4), pp. 562–569. DOI: 10.1038/s41564-020-0688-y
6. Popova R.V., Ruzhentsova T.A., Khavkina D.A., Chukhlyaev P.V., Garbuzov A.A., Meshkova N.A. Disorders of the function of the gastrointestinal tract in children with COVID-19. Problemy osobo opasnykh infektsiy, 2020, no. 3, pp. 154–157 (in Russ.). DOI: 10.21055/0370-1069-2020-3-154-157.7
7. Guan W.J., Ni Z.Y., Hu Y. et al.; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 2020, vol. 382 (18), pp. 1708–1720. DOI: 10.1056/NEJMoa2002032
8. Zhang J.J., Dong X., Cao Y.Y. et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 2020. DOI: 10.1111/all.14238 PMID: 32077115.
9. Pakhomova I.G. At the reception, a patient with dyspepsia after suffering a new coronavirus infection (Covid-19). Possible ways of solving the problem. Trudnyy patsient, 2021, no. 19 (2), pp. 46–50 (in Russ.). DOI: 10.224412/2074-1005-2021-2-46-50
10. Grinevich V.B., Kravchuk Yu.A., Ped’ V.I., Sas E.I, Salikova S.P., Gubonina I.V., Tkachenko E.I., Sitkin S.I., Lazebnik L.B., Golovanova E.V. Management of patients with diseases of the digestive system during the COVID-19 pandemic. Clinical recommendations of the Scientific Society of Gastroenterologists of Russia. Eksperimental’naya i klinicheskaya gastroenterologiya, 2020, no. 179 (7), pp. 4–51 (in Russ.). DOI: 10.31146/1682-8658-ecg-179-7-4-51
11. Pimanov S.I., Dikareva E.A. Gastroenterological manifestations of COVID-19: first generalizations. Klinicheskiy razbor v obshchey meditsine, 2020, no. 1, pp. 6–13 (in Russ.). DOI: 10.47407/kr2020.1.1.00001
12. Saidov S.S., Smetneva N.S., Davydova S.S., Kalinina N.N., Chekal’nikov D.A. The prevalence of symptoms of lesions of the gastrointestinal tract among the clinical manifestations of COVID-19. Vestnik meditsinskogo instituta «REAVIZ», 2021, no. 3, pp. 5–12 (in Russ.). DOI: 10.20340/vmi-rvz.2021.3.COVID.1
13. Tsukanov V.V., Rzhavicheva O.S., Vasyutin A.V., Dunaevskaya O.V., Tonkikh Yu.L., Bronnikova E.P. The effectiveness of Colofort in the treatment of patients with irritable bowel syndrome. Terapevticheskiy arkhiv, 2016, no. 88 (8), pp. 40–45 (in Russ.).